Search Results for: Masayo Takahashi

WAFSF stem cell vision talks: Hinton, Tsukamoto, Klassen, Takahashi

February 1, 2021 / By / 6 Comments
Henry-Klassen

Recently I was at the World Alliance Forum in San Francisco (WAFSF), a great meeting on stem cells and regenerative medicine. WAFSF had some excellent talks and I saw one session on the use of stem cells to treat vision impairment that was particularly striking. World Alliance Forum in San Francisco (WAFSF) This session’s all-star lineup included Drs. David …

WAFSF stem cell vision talks: Hinton, Tsukamoto, Klassen, Takahashi Read More »

Weekly reads: Melton leaves Harvard, Fuji, BBC blunder, stem cell niche, more

April 9, 2022 / By / Leave a Comment
Senolytics restore the stem cell niche in the brains of mice. Fatt, et al. Stem Cell Reports 2022.

Sometimes a post here on The Niche (named after the stem cell niche) sparks a debate between expert stem cell researchers and often that gives much more depth to a topic. Such was the case with my post this week on where things stand with stem cell therapy for heart disease. It led to a …

Weekly reads: Melton leaves Harvard, Fuji, BBC blunder, stem cell niche, more Read More »

2021 scorecard for stem cell stocks: REGN, VCEL, CCEL, LCTX did best

December 20, 2021 / By / 3 Comments
Mesoblast stock

A quick review of the publicly-traded stem cell stocks I’ve been following in 2021 finds mostly discouraging news, but a few firms relatively outperformed the other publically-traded biotechs. One had some great news today. In this post, I’m doing a brief overview of how things went this year in the regenerative medicine space. I’m going …

2021 scorecard for stem cell stocks: REGN, VCEL, CCEL, LCTX did best Read More »

Weekly reads: Stem cells for vision loss & recommended pubs

April 25, 2021 / By / 3 Comments
stem cells for vision loss ribeiro et al

I’m going to start off today’s recommended reads post with some stem cells for vision developments. I had some fun the last 2 weeks as people sent in their entries for our $100 stem cell picture contest. I’ll announce the winner this week. It’s going to be hard to choose given the great entries. Stem …

Weekly reads: Stem cells for vision loss & recommended pubs Read More »

What are induced pluripotent stem cells or IPS cells?

May 31, 2023 / By / 6 Comments
induced pluripotent stem cells clinical trials map

Induced pluripotent stem cells or iPS cells just might be the most exciting development in the stem cell field over the last 15 years. They have unique potential for clinical impact for regenerative medicine too. This may manifest both through their use to produce differentiated cellular therapies and indirectly via disease modeling as well as …

What are induced pluripotent stem cells or IPS cells? Read More »

Grading my 20 stem cell predictions for 2020

February 1, 2021 / By / 1 Comment
Knoepfler-The-Niche-stem-cell-blog-predictions-2020

Each year I metaphorically try to look into a crystal ball for stem cell predictions for the coming year and I did so for 2020, but the COVID-19 pandemic threw a monkey wrench into my predictions. It actually kind of blew some up. It also raised some interesting questions and dilemmas. For instance, do many …

Grading my 20 stem cell predictions for 2020 Read More »

Overview of IPS cell prospects for clinical impact

June 8, 2022 / By / Leave a Comment
IPS-cell-clincial-trials-map

IPS cell research is a growing area of promise for regenerative medicine. These stem cells, also known as iPSCs or more formally as Induced Pluripotent Stem Cells, are engineered cells that are programmed to function the same way as embryonic stem cells. They can be differentiated into possibly any type of cell that is needed for …

Overview of IPS cell prospects for clinical impact Read More »

IPS cell field update: easy culture, Parkinson’s, scarring, immune cells, & mutations

February 1, 2021 / By / 1 Comment
Fibrosis-model-IPS-cells-Fig-1b-Vijayaraj-et-al-Cell-Reports-2019

Where do things stand today in 2020 with IPS cell research? It’s been 14 years since they were first reported, but they continue to make news. Back in 2006 I was wrapping up my postdoc with Bob Eisenman at The Hutch in Seattle, largely studying Myc, when Shinya Yamanaka published his first induced pluripotent stem …

IPS cell field update: easy culture, Parkinson’s, scarring, immune cells, & mutations Read More »